DK2069395T3 - Nye antigener og antistoffer associeret med adenokarcinom i pancreaskanalen - Google Patents
Nye antigener og antistoffer associeret med adenokarcinom i pancreaskanalenInfo
- Publication number
- DK2069395T3 DK2069395T3 DK07820692.7T DK07820692T DK2069395T3 DK 2069395 T3 DK2069395 T3 DK 2069395T3 DK 07820692 T DK07820692 T DK 07820692T DK 2069395 T3 DK2069395 T3 DK 2069395T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibodies
- pda
- adenocarcinoma
- pancreatic duct
- identified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G01N33/57525—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01011—Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
-
- G01N33/575—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06121552 | 2006-09-29 | ||
| EP06126726 | 2006-12-20 | ||
| PCT/EP2007/060305 WO2008037792A1 (en) | 2006-09-29 | 2007-09-28 | Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2069395T3 true DK2069395T3 (da) | 2012-05-14 |
Family
ID=38895810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07820692.7T DK2069395T3 (da) | 2006-09-29 | 2007-09-28 | Nye antigener og antistoffer associeret med adenokarcinom i pancreaskanalen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8071721B2 (enExample) |
| EP (1) | EP2069395B1 (enExample) |
| JP (1) | JP2010505104A (enExample) |
| KR (1) | KR20090094227A (enExample) |
| CN (1) | CN101578295B (enExample) |
| AT (1) | ATE542831T1 (enExample) |
| AU (1) | AU2007301966B2 (enExample) |
| BR (1) | BRPI0717282A2 (enExample) |
| CA (1) | CA2664841A1 (enExample) |
| DK (1) | DK2069395T3 (enExample) |
| EA (1) | EA016731B1 (enExample) |
| ES (1) | ES2381304T3 (enExample) |
| IL (2) | IL197868A (enExample) |
| NO (1) | NO20091662L (enExample) |
| NZ (1) | NZ576409A (enExample) |
| PL (1) | PL2069395T3 (enExample) |
| PT (1) | PT2069395E (enExample) |
| WO (1) | WO2008037792A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009137832A2 (en) * | 2008-05-09 | 2009-11-12 | Duke University | Autoantibodies in the detection and treatment of cancer |
| IT1398782B1 (it) * | 2009-09-11 | 2013-03-18 | Novelli | Peptide monofosforilato isolato derivato dall'alfa-enolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi. |
| ITTO20120523A1 (it) * | 2012-06-15 | 2013-12-16 | Natimab Therapeutics S R L | Procedimento e kit per la diagnosi in vitro dell'adenocarcinoma duttale pancreatico o per determinare la predisposizione all'adenocarcinoma duttale pancreatico |
| EP3083697B1 (en) * | 2013-12-20 | 2019-04-17 | Development Center for Biotechnology | Alpha-enolase specific antibodies and methods of uses in cancer therapy |
| WO2015106296A1 (en) | 2014-01-13 | 2015-07-16 | Berg Llc | Enolse 1 (eno1) compositions and uses thereof |
| CN115786317A (zh) * | 2022-12-12 | 2023-03-14 | 江苏三联生物工程股份有限公司 | 重组神经元特异性烯醇化酶及其制备方法与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5753446A (en) * | 1993-04-15 | 1998-05-19 | National Jewish Center For Immunology & Respiratory Medicine | Mitogen ERK kinase kinase (MEKK) assay |
-
2007
- 2007-09-28 NZ NZ576409A patent/NZ576409A/en not_active IP Right Cessation
- 2007-09-28 PL PL07820692T patent/PL2069395T3/pl unknown
- 2007-09-28 ES ES07820692T patent/ES2381304T3/es active Active
- 2007-09-28 AU AU2007301966A patent/AU2007301966B2/en not_active Ceased
- 2007-09-28 US US12/443,576 patent/US8071721B2/en not_active Expired - Fee Related
- 2007-09-28 JP JP2009529713A patent/JP2010505104A/ja active Pending
- 2007-09-28 EP EP07820692A patent/EP2069395B1/en active Active
- 2007-09-28 WO PCT/EP2007/060305 patent/WO2008037792A1/en not_active Ceased
- 2007-09-28 DK DK07820692.7T patent/DK2069395T3/da active
- 2007-09-28 CN CN2007800423663A patent/CN101578295B/zh not_active Expired - Fee Related
- 2007-09-28 PT PT07820692T patent/PT2069395E/pt unknown
- 2007-09-28 CA CA002664841A patent/CA2664841A1/en not_active Abandoned
- 2007-09-28 KR KR1020097008777A patent/KR20090094227A/ko not_active Withdrawn
- 2007-09-28 BR BRPI0717282-6A patent/BRPI0717282A2/pt not_active IP Right Cessation
- 2007-09-28 AT AT07820692T patent/ATE542831T1/de active
- 2007-09-28 EA EA200970332A patent/EA016731B1/ru not_active IP Right Cessation
-
2009
- 2009-03-26 IL IL197868A patent/IL197868A/en not_active IP Right Cessation
- 2009-04-27 NO NO20091662A patent/NO20091662L/no not_active Application Discontinuation
-
2012
- 2012-03-01 IL IL218442A patent/IL218442A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007301966B2 (en) | 2013-02-21 |
| ES2381304T3 (es) | 2012-05-25 |
| AU2007301966A1 (en) | 2008-04-03 |
| KR20090094227A (ko) | 2009-09-04 |
| WO2008037792A1 (en) | 2008-04-03 |
| IL218442A0 (en) | 2012-04-30 |
| IL197868A0 (en) | 2011-08-01 |
| EA200970332A1 (ru) | 2009-10-30 |
| CA2664841A1 (en) | 2008-04-03 |
| ATE542831T1 (de) | 2012-02-15 |
| PT2069395E (pt) | 2012-04-27 |
| US8071721B2 (en) | 2011-12-06 |
| NZ576409A (en) | 2012-02-24 |
| IL197868A (en) | 2013-03-24 |
| JP2010505104A (ja) | 2010-02-18 |
| US20100028907A1 (en) | 2010-02-04 |
| BRPI0717282A2 (pt) | 2013-10-15 |
| EP2069395A1 (en) | 2009-06-17 |
| CN101578295B (zh) | 2013-02-27 |
| NO20091662L (no) | 2009-06-29 |
| PL2069395T3 (pl) | 2012-06-29 |
| EA016731B1 (ru) | 2012-07-30 |
| EP2069395B1 (en) | 2012-01-25 |
| CN101578295A (zh) | 2009-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY162056A (en) | Diagnosis and treatment of cancer using anti -ereg antibody | |
| EP3885366A3 (en) | Therapeutic antibodies against ror-1 protein and methods for use of same | |
| CY1117236T1 (el) | Μονοκλωνικα αντισωματα εναντι γλυπικανης-3 | |
| CY1118979T1 (el) | Αντισωματα που κατευθυνονται εναντι her-3 και χρησεις αυτων | |
| PH12015500093A1 (en) | Il-17 binding proteins | |
| IL218442A0 (en) | Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma | |
| MX2009013824A (es) | Proteinas de enlace de antigeno que enlazan par-2. | |
| MY150400A (en) | Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof | |
| CY1118714T1 (el) | Υψηλης συγγενειας ανθρωπινα αντισωματα κατα του ανθρωπινου ενεργοποιουμενου απο πρωτεαση υποδοχεα-2 | |
| CY1119539T1 (el) | Πληρως ανθρωπινα αντισωματα ειδικα για to cadμ1 | |
| MX2008009886A (es) | Anticuerpos que enlazan par-2. | |
| EA201492253A1 (ru) | Конструкторы, связывающиеся с ron, и способы их использования | |
| UA113712C2 (xx) | Антитіло до fap і способи його застосування | |
| BRPI0808940A8 (pt) | anticorpo humano ou fragmento de ligação do mesmo, antígeno, polinucleotídeo, vetor, célula hospedeira, método para preparar um anticorpo ou um fragmento de ligação ou cadeia(s) de imunoglobulina do mesmo, anticorpo, cadeia de imunoglobulina ou um fragmento de ligação do mesmo, composição, usos do anticorpo ou fragmento de ligação, de um antígeno, de um polinucleotídeo, de um vetor, ou de uma célula, e de uma molécula de ligação a antígeno tumoral, método para clonagem molecular de um anticorpo, e, kit para o diagnóstico de um tumor | |
| MX2024003355A (es) | Anticuerpos anti-cd3. | |
| NO20091181L (no) | Anti-C5AR-antistoffer med forbedrede egenskaper | |
| UA99602C2 (ru) | Антитело, специфически связывающееся с jam-a, способное ингибировать пролиферацию опухолевых клеток | |
| NO20084795L (no) | Fremgangsmate for a behandle, diagnostisere eller detektere kreft | |
| EA200702361A1 (ru) | АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ | |
| BR112012024997A2 (pt) | peptídeos ect2 e vacinas incluindo os mesmos | |
| BR112012022641A2 (pt) | peptídeos hjurp e vacinas que incluem os mesmos | |
| MY192517A (en) | Antibody specifically binding to pauf protein and use thereof | |
| ATE502123T1 (de) | Verfahren und zusammensetzungen zur diagnose und behandlung von krebs | |
| NO20091239L (no) | Konjugater av disorazoler og deres derivater med celle bindingsmolekyler, nye disorazol derivater, fremgangsmate for fremstilling og anvendelse derav | |
| WO2006116681A3 (en) | Tat-003 and methods of assessing and treating cancer |